Thymia
PrivateLast Round
Seed
Jul 27, 2023
Est. Valuation
$17.23M
Total Funding Raised
$3.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Thymia is a healthcare technology company that develops AI-powered platforms using video games and multimedia analysis to provide objective assessments and tracking for mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Thymia Comparables
Compare Thymia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Canary Speech | 80% | |
| Kintsugi | 78% | |
| Aiberry | 78% |
Thymia Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Thymia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kodori AG | Seed |
| Calm/Storm Ventures | Seed |
| Form Ventures | Seed |
| Entrepreneurs First | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 59% MoM.
- Jul 27, 2023
$2.7M round led by Kodori AG.
Recent news
Latest coverage and updates
- is_developingOct 8, 2026
Thymia Limited, working with RMIT University researchers in Australia, develops an AI model that analyzes about 20 seconds of speech to identify patterns associated with type 2 diabetes; researchers train it on more than 63,000 voice samples and present the research at the 2026 annual meeting of the European Association for the Study of Diabetes.
- is_developingOct 1, 2026
Thymia Limited, in cooperation with Australia's RMIT University, developed a model that analyzes voice characteristics to identify indicators of type 2 diabetes from recordings of up to 20 seconds.
Thymia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Thymia's valuation, stock price, and market status.
Is Thymia a public or private company?
Thymia is a private company.
What is the current stock price of Thymia?
Thymia is a private company, so its shares have no public market price. Caplight tracks Thymia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Thymia worth (valuation)?
Thymia's valuation is estimated at $17.2M based on funding round data.
Can I buy Thymia stock?
Thymia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Thymia's last funding round?
Thymia's most recent funding round was Seed on July 27, 2023.
Who are the main investors in Thymia?
Key investors in Thymia include Kodori AG, Calm/Storm Ventures.
Will Thymia IPO soon?
No public IPO plans have been announced for Thymia.
How can I track Thymia secondary market activity?
Caplight tracks bids, offers, and trades in Thymia's shares on secondary markets.